SCHEMBL26306451

SCHEMBL26306451

Clc1ccc(-c2ccc(N(c3ccccc3)c3cccc4sc5ccccc5c34)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 2/20 0.38
CYP1A2 P05177 2/20 0.37
KDM4E B2RXH2 1/20 0.36
GPR3 P46089 1/20 0.34
APP P05067 1/20 0.33
CHKA P35790 2/20 0.32
GABRA1 P14867 1/20 0.32
GABRA5 P31644 1/20 0.32
MCL1 Q07820 2/20 0.31
CYP1A1 P04798 1/20 0.31
CYP1B1 Q16678 1/20 0.31
PRSS12 P56730 1/20 0.31
PTPN1 P18031 2/20 0.30
LMNA P02545 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
MAPT P10636 2/20 0.30
MEN1 O00255 1/20 0.30
POLB P06746 1/20 0.30
DUSP3 P51452 1/20 0.30
BLM P54132 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23765164 0.90 PTGDR2 (0.36) PTGDR2CYP1A2KDM4ECHKACYP1A1
SCHEMBL16559108 0.87 GPR3 (0.45) CYP1A2KDM4EGPR3APPMCL1
SCHEMBL24472033 0.86 GPR3 (0.34) GPR3APPMCL1PTPN1MAPT
SCHEMBL24472044 0.86 GPR3 (0.34) GPR3APPMCL1PTPN1MAPT
SCHEMBL24472632 0.86 GPR3 (0.34) GPR3APPMCL1PTPN1MAPT
SCHEMBL22403591 0.86 KDM4E (0.34) CYP1A2KDM4EGPR3GABRA1GABRA5
SCHEMBL21398871 0.85 GPR3 (0.33) KDM4EGPR3APPMCL1MAPT
SCHEMBL24471805 0.85 APP (0.35) CYP1A2KDM4EGPR3APPMAPT
SCHEMBL21214777 0.85 F9 (0.39) GPR3APPMCL1PTPN1MAPT
SCHEMBL21206193 0.85 F9 (0.36) GPR3APPMCL1PTPN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12048240-B2 Organic compound, electronic component and electronic apparatus comprising the same SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2024-07-23 US disclosed
US-12048240-B2 Organic compound, electronic component and electronic apparatus comprising the same SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2024-07-23 US disclosed
WO-2023160121-A1 ORGANIC COMPOUND, ELECTRONIC ELEMENT COMPRISING SAME, AND ELECTRONIC DEVICE 陕西莱特光电材料股份有限公司 2023-08-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12048240-B2 Organic compound, electronic component and electronic apparatus comprising the same PIEZO1, OCIAD1, OSTC PTGDR2 4148/4885CYP1A2 213/4885KDM4E 2401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.